Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Prehabilitation with physiotherapy and mechanical stimulation before LD flap breast reconstruction

Official title: Randomized, Multicentre Study Evaluating the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi Flap

Run by Institut du Cancer de Montpellier - Val d'Aurelle · NCT07418060 · Data updated 2026-11-12

This study tests whether prehabilitation with physiotherapy and mechanostimulation improves shoulder pain and mobility for women undergoing breast reconstruction with a latissimus dorsi flap.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment96 (estimated)
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Academic / other
Locations2 sites (Bordeaux, Aquitaine and 1 other locations)
StatusRecruiting
StartedAugust 28, 2026
Main results expectedJuly 2030
Study endsJuly 2030
Registry record updatedSeptember 15, 2026
Trial IDNCT07418060 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women (18 years or older) scheduled for breast reconstruction with a latissimus dorsi flap after breast cancer.

Probably not a fit

Individuals with pre-existing shoulder pathology or other factors excluding them from the study may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients scheduled for breast reconstruction using a latissimus dorsi flap are randomized to receive a structured prehabilitation program with physiotherapy and mechanostimulation versus standard care without prehabilitation. The trial aims to determine if the preparatory rehabilitation reduces postoperative shoulder pain and improves range of motion and function. Procedures are conducted in France at multiple centers, enrolling adults who meet eligibility criteria and can understand French. The intervention is non-pharmacologic and focused on preoperative optimization of shoulder health. Outcomes likely include pain scores, mobility measures, and patient-reported function.

Why it matters

Potential benefit: If successful, patients may experience less shoulder pain and better shoulder mobility after reconstruction, improving recovery and quality of life.

How similar studies have gone: Previous surgical rehabilitation studies suggest rehabilitation approaches can improve postoperative shoulder function, but this exact prehabilitation with mechanostimulation before LD flap reconstruction is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patient aged 18 years or older
* Scheduled for breast reconstruction with a latissimus dorsi flap following breast cancer
* Patient has been informed and has signed the informed consent form
* Affiliated with a social security system

Exclusion Criteria:

* Patient with pre-existing shoulder pathology (Constant score \< 80/100)
* Patient with uncontrolled psychiatric or mental disorders
* Patient unable to understand French
* Patient under guardianship or safeguard of justice
* Pregnant or breastfeeding women

Where it's running

  • Institut régional du Cancer de Montpellier
    Montpellier, Herault, France
    Recruiting
  • Institut Bergonié
    Bordeaux, Aquitaine, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.